AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders and Presentation SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast their Annual Meeting of Stockholders on Wednesday, May 25, 2005 at 10:00 a.m. Pacific Time from the company's corporate headquarters in San Diego, CA. Following the Annual Meeting, Ginger Graham, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview, and Dr. Steven Edelman, Professor of Medicine, Division of Endocrinology & Metabolism, University of San Diego and Director, Diabetes Care Clinic, Veterans Affairs Medical Center, San Diego, will provide a physician's perspective on current diabetes treatments. The live presentation will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright